s6y
Company name or ticker
Search
Axsome Therapeutics, Inc.
ARS
Annual report to security holders
Filed
Friday, April 21, 2023
Period
Dec 31, 2022
Accession number
0000950170-23-013884
Documents
ARS
ARS
On sec.gov
Filing index
All files
Complete submission text
SGML header